Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine
Table 4
Laboratory markers in peripheral blood before vaccination.
Factor
PPV + JTT ()
PPV alone ()
value
Hemoglobin (g/dL)
0.4821
Lymphocyte count (/mm3)
0.8732
Albumin (g/dL)
0.0895
Creatinine (mg/dL)
0.6791
Total bilirubin (mg/dL)
0.7829
IL-2 (pg/mL)
0.3800
IL-4 (pg/mL)
0.3160
IL-5 (pg/mL)
0.8965
IL-6 (pg/mL)
0.5134
IL-10 (pg/mL)
0.3415
IL-12 (pg/mL)
0.5433
IL-18 (pg/mL)
0.9731
IFN- (pg/mL)
0.4495
TGF-1 (ng/mL)
0.7278
C-reactive protein (mg/dL)
0.2015
Serum amyloid A (g/mL)
0.1505
d-ROM (U.CARR)†
0.2424
BAP‡ (mol/L)
0.7442
Values are means ± standard deviations. †d-ROM: derivatives of reactive oxidative metabolites: U.CARR, Carratelli unit (1 Carratelli unit = 0.8 mg H2O2/L). ‡BAP: biological antioxidant potential.